MedTrace Logo

Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma

NCT06671431 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 578

Last updated 2024-11-04

No results posted yet for this study

Summary

Recent studies addressing the role of adjuvant chemotherapy in cholangiocarcinoma (CCA) have been published; however, there are challenges in generalizing the findings due to different prognostic characteristics depending on tumor location and resectability. Therefore, the aim of this study was to investigate the role of AC in distal cholangiocarcinoma, a common tumor subtype of CCA.

Conditions

  • Distal Cholangiocarcinoma
  • Adjuvant Chemotherapy

Interventions

DRUG

Adjuvant chemotherapy

Adjuvant chemotherapy with or without radiotherapy

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2021-12-31
Completion
2024-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06671431 on ClinicalTrials.gov